English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Advertisement
    Remove Ad
    HomeNewsBusinessmoneycontrol ResearchWeekly Tactics | Lupin: Focus on inhalation and bio-similars to aid margins in medium term

    Weekly Tactics | Lupin: Focus on inhalation and bio-similars to aid margins in medium term

    In the medium term, the focus is likely to be on the inhalation and biosimilar categories for Lupin, with scale-up in both US and European markets

    June 16, 2021 / 17:07 IST
    • PRO Panorama

      Ideas For Profit | Fiem Industries: Can this auto ancillary stock gain despite industry challenges?

      Jun 14, 2022 / 08:38 PM IST

      Fiem Industries posted a strong set of numbers in Q4FY22, despite significant demand weakness in the two-wheeler industry and comm...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts

    Disclosure & Disclaimer

    This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More